Literature DB >> 11196322

Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP.

Y S Bian1, P Yan, M C Osterheld, C Fontolliet, J Benhattar.   

Abstract

Methylation-sensitive single-strand conformation analysis (MS-SSCA) is a new method of screening for DNA methylation changes. The combination of bisulfite modification and PCR results in the conversion of unmethylated cytosines to thymines, whereas methylated cytosines remain unchanged. This sequence conversion can lead to methylation-dependent alterations of single-strand conformation, which can be detected by SSCA. An analysis of mixtures of methylated and unmethylated DNA at known ratios revealed that the relative intensities of the corresponding bands following MS-SSCA were maintained. MS-SSCA was applied for methylation analysis of human p16 promoter region using genomic DNA obtained from either frozen, fixed, or microdissected fixed tissue sections. MS-SSCA is a rapid, specific, and semiquantitative approach that allows the detection of methylation of the p16 gene promoter. In reconstruction experiments, the method permits the detection of 10% or less of cells harboring a methylated p16 promoter. We have been successful in analyzing by MS-SSCA almost all (96%) tumor samples microdissected from archival paraffin-embedded fixed tissue sections and obtaining reproducible results. In addition, when microdissection was performed, the clonality of this genetic alteration could be identified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11196322     DOI: 10.2144/01301st02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  8 in total

1.  A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples.

Authors:  G Clément; J Benhattar
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 2.  Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.

Authors:  Shuk-mei Ho; Wan-yee Tang
Journal:  Reprod Toxicol       Date:  2007-01-19       Impact factor: 3.143

3.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.

Authors:  M van Rijnsoever; F Grieu; H Elsaleh; D Joseph; B Iacopetta
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.

Authors:  Wei-Cheng Xue; Kelvin Y K Chan; Hui-Chen Feng; Pui-Man Chiu; Hextan Y S Ngan; Sai-Wah Tsao; Annie N Y Cheung
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

5.  hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells.

Authors:  Cristina Valls-Bautista; Stéphanie Bougel; Carme Piñol-Felis; Joan Viñas-Salas; Jean Benhattar
Journal:  Oncol Lett       Date:  2011-08-18       Impact factor: 2.967

Review 6.  DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.

Authors:  Sandra Mersakova; Marcela Nachajova; Peter Szepe; Petra Sumichrastova Kasajova; Erika Halasova
Journal:  Tumour Biol       Date:  2015-10-12

7.  PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.

Authors:  Stéphanie Bougel; Stéphanie Renaud; Richard Braunschweig; Dmitri Loukinov; Herbert C Morse; Fred T Bosman; Victor Lobanenkov; Jean Benhattar
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

8.  Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues.

Authors:  Jianqiang Wu; Katrin A Salva; Nathalie Stutz; B Jack Longley; Vladimir S Spiegelman; Gary S Wood
Journal:  Exp Dermatol       Date:  2014-05       Impact factor: 3.960

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.